These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 12077654)
21. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy. Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190 [TBL] [Abstract][Full Text] [Related]
22. Midcourse thallium-201 scintigraphy to predict tumor response in bone and soft-tissue tumors. Sumiya H; Taki J; Tsuchiya H; Nonomura A; Miyauchi T; Tonami N J Nucl Med; 1998 Sep; 39(9):1600-4. PubMed ID: 9744351 [TBL] [Abstract][Full Text] [Related]
23. Quantitative thallium-201 scintigraphy in childhood osteosarcoma: Comparison with technetuim-99m MDP and magnetic resonance imaging in the evaluation of chemotherapeutic response. Ilhan IE; Vural G; Berberoglu S; Kapucuoglu N; Cila A; Eke S Pediatr Hematol Oncol; 2005 Mar; 22(2):153-62. PubMed ID: 15805001 [TBL] [Abstract][Full Text] [Related]
24. Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas. Kostakoglu L; Panicek DM; Divgi CR; Botet J; Healey J; Larson SM; Abdel-Dayem HM Eur J Nucl Med; 1995 Nov; 22(11):1232-7. PubMed ID: 8575469 [TBL] [Abstract][Full Text] [Related]
25. Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma. Lin J; Leung WT; Ho SK; Ho KC; Kumta SM; Metreweli C; Johnson PJ Eur J Nucl Med; 1995 Jun; 22(6):553-5. PubMed ID: 7556302 [TBL] [Abstract][Full Text] [Related]
26. Multiple myeloma evaluated with 201Tl scintigraphy compared with bone scintigraphy. Watanabe N; Shimizu M; Kageyama M; Tanimura K; Kinuya S; Shuke N; Yokoyama K; Tonami N; Watanabe A; Seto H; Goodwin DA J Nucl Med; 1999 Jul; 40(7):1138-42. PubMed ID: 10405133 [TBL] [Abstract][Full Text] [Related]
27. Thallium-201 chloride scintigraphy in soft tissue tumors. Otsuka H; Terazawa K; Morita N; Otomi Y; Takao S; Iwamoto S; Osaki K; Harada M; Nishitani H J Med Invest; 2009 Aug; 56(3-4):136-41. PubMed ID: 19763026 [TBL] [Abstract][Full Text] [Related]
28. Routine 201Tl scintigraphy in the follow-up of patients with differentiated thyroid carcinoma: diagnostic accuracy and clinical impact. Hsu CC; Chen YW; Huang YF; Chuang YW Nucl Med Commun; 2007 Sep; 28(9):681-7. PubMed ID: 17667746 [TBL] [Abstract][Full Text] [Related]
29. Imaging assessment of the responses of osteosarcoma patients to preoperative chemotherapy: angiography compared with thallium-201 scintigraphy. Kunisada T; Ozaki T; Kawai A; Sugihara S; Taguchi K; Inoue H Cancer; 1999 Sep; 86(6):949-56. PubMed ID: 10491520 [TBL] [Abstract][Full Text] [Related]
34. [Clinical usefulness of 201Tl-chloride scintigraphy for the diagnosis of bone metastases]. Koyama M Kaku Igaku; 1995 Jan; 32(1):9-18. PubMed ID: 7897873 [TBL] [Abstract][Full Text] [Related]
35. The use of thallium-201 in the preoperative detection of breast cancer: an adjunct to mammography and ultrasonography. Cimitan M; Volpe R; Candiani E; Gusso G; Ruffo R; Borsatti E; Massarut S; Rossi C; Morassut S; Carbone A Eur J Nucl Med; 1995 Oct; 22(10):1110-7. PubMed ID: 8542893 [TBL] [Abstract][Full Text] [Related]
36. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy. Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390 [TBL] [Abstract][Full Text] [Related]
37. [Evaluation of malignancy and viability of brain tumors by 201Tl SPECT: the correlation between 201Tl SPECT and pathology, clinical progress and the intensity of enhancement on CT images]. Ohnishi H; Koizumi K; Uchiyama G; Yamaguchi M; Okada J; Ogata H; Toyama K; Monzawa S; Oba H; Araki T Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Dec; 54(14):1388-98. PubMed ID: 7596768 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of palpable breast masses with 201Tl scintigraphy. Rebollo AC; Torres-Avisbal M; Espinosa JE; Diaz C; Vallejo JA; Pacheco C; Pera C; Mateo A Br J Radiol; 1995 Oct; 68(814):1052-7. PubMed ID: 7496703 [TBL] [Abstract][Full Text] [Related]
39. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma. Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573 [TBL] [Abstract][Full Text] [Related]
40. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities. Moustafa H; Riad R; Omar W; Zaher A; Ebied E Q J Nucl Med; 2003 Mar; 47(1):51-7. PubMed ID: 12714955 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]